LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Multiplex Assay Detects Pathogens in NF Patients

By LabMedica International staff writers
Posted on 23 Apr 2019
Print article
Image: An area of mild erythema around varicella lesion on the thigh of a young boy progressed to necrotizing fasciitis caused by group A Streptococcus (Photo courtesy of Dr. E. P. Dellinger, MD).
Image: An area of mild erythema around varicella lesion on the thigh of a young boy progressed to necrotizing fasciitis caused by group A Streptococcus (Photo courtesy of Dr. E. P. Dellinger, MD).
Necrotizing fasciitis (NF) is a life-threatening deep soft tissue infection characterized by rapidly progressive necrosis of the fascia and the adjacent soft tissues. NF of the extremities is associated with high mortality rates, and immediate surgical intervention is required upon detection of NF infections.

Early diagnosis and bacterial identification are essential for adequate surgical treatment and appropriate antibiotic administration in patients with NF. The clinical signs and symptoms of NF caused by Gram-positive and Gram-negative microorganisms are characteristically indistinguishable at the time of presentation. Moreover, it takes 3 to 4 days to obtain the results of microbiological analysis and antimicrobial sensitivity testing of the specimens.

Scientists from Chang Gung Memorial Hospital (Taoyuan City, Taiwan) collected samples from 99 patients with surgically confirmed NF of the extremities who were hospitalized consecutively between June 2015 and November 2017. Two sets of blood and tissue samples were collected from all patients; one set was sent to a microbiology laboratory for bacterial identification and the other set was sent to an immunohistochemistry laboratory for polymerase chain reaction (PCR) amplification.

The culture specimens were obtained from the infected wounds or the blood, and were identified by microbiological evaluation. Genomic bacterial DNA extraction was performed and 16S rDNA universal PCR was performed for each sample to validate the results of the multiplex PCR assay. Total genomic DNA was purified using a Geneaid Bacteria Genomic DNA Kit and amplified. PCR amplicons were analyzed by electrophoresis in 2% agarose gel.

The multiplex PCR results for the blood samples showed negative findings. The multiplex PCR results for the tissue specimens showed 28 positive findings. Fourteen (87.5%) of the 16 Vibrio vulnificus culture-positive tissue specimens, six (75%) of the eight Aeromonas hydrophila culture-positive tissue specimens, and four (100%) of the four methicillin-resistant Staphylococcus aureus (MRSA) culture-positive tissue specimens were positive by PCR. Similarly, two (100%) of the group A Streptococcus and two (100%) of the group B Streptococcus were PCR-positive.

The authors concluded that the accuracy rate of the multiplex PCR presenting positive results in these culture-positive tissue samples was 87.5% (28/32). This suggests that multiplex PCR of tissue specimens may be a useful and rapid diagnostic tool for the detection of these lethal microorganisms in patients with NF. The study was published in the April 2019 issue of the International Journal of Infectious Diseases.

Related Links:
Chang Gung Memorial Hospital

Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Community-Acquired Pneumonia Test
RIDA UNITY CAP Bac
New
Multi-Function Pipetting Platform
apricot PP5

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.